Dr. Web has refused to participate in testing of anti-virus programs VirusBulletin100
The August testing of anti-virus products VirusBulletin100 which are conducted by one of authoritative British journals, for the first time for the history has passed without sharing of Russian antivirus Dr. Web. Vendoryi protective ON notice, that technique VirusBulletin100 ceases to meet the requirements of test of anti-virus products.
Russian Dr. Web has refused to pass August test of anti-virus programs VirusBulletin100. It is the first case of failure of the Russian anti-virus manufacturer from the test which are conducted by the ritish journal with the same name
The essence of testing VB100 consists in check by the anti-virus module of collections of "wild viruses» (Wildlist) and «pure files» (Clean Sets). The antivirus which not passed any copy from the first list and has "not named" with a virus of any file from the second list, receives award VB100 of %.
However, according to independent virus analysts, recently this technique hardly has become outdated and cannot be considered adequate for definition of quality of an antivirus. It is connected by that testers do not open structure of both collections, but it is known, that Wildlist replenishes extremely slowly and only with certain types of viruses — under Windows. Claims from anti-virus vendorov also concern also quantities of viruses in a collection — April VB100 passed on 700 viruses, and August has increased only by some tens semplov.
Except testing on Wildlist, experts VirusBulletin in addition remove results of testing on own selection of viruses (column Worms, File inspectors, Polimorphic and Trojans) which do not influence reception of award VB100. According to Ivan Stogova, the expert of portal Anti-Malware, anti-virus vendoryi leave test Virus Bulletin as recognise its technique of the inappropriate validity. These demarches Trend Micro and Dr. Web (and the first of them has made Panda Antivirus in 2003) are attempt to show uscherbnost VB100 in its present condition.
As Boris Sharov, director Dr has noted . Web, selection VirusBulletin covers only 10-15 % of all harmful ON: «the Basic criterion of drawing up Wildlist is replitsiruemost (reproducibility) of viruses, therefore the various polymorphic Trojan programs making to 80 % of detected viruses, do not enter into it. For this reason to judge quality of an antivirus on test passage on such small quantity of a material it is not necessary».
«Remained in the test vendoryi, such as Eset and Symantec (especially the first) already historically build the advertising strategy on VB100 % and are specially sharpened under its passage. To criticise, and furthermore from this test for them to leave absolutely unprofitable. Others as« Kaspersky’s Laboratory », understand, that the test is imperfect, but participate in it by inertia», — Ivan Stogov adds.
Some other point of view adheres Vitaly Janko, sales manager Agnitum: «Despite partially reasonable applications about" to loss by the test and award VB100 of weight and authority "in the resume of the last report VB100 accessible to subscribers, it is informed on significant revision of techniques which will be fulfilled during the nearest testings. In the same place promises" are given to complicate a life "to many decisions which applied earlier for the award or received it». In comment CNews, mister Janko, has underlined, that absence in VB100 Dr. Web and Trend Micro are dictated «by the different reasons — for one company it without delay the reasons of technical character, and for other — political».
Let’s remind, that company Trend Micro declared the exit from tests VB100 in the beginning of June, criticising organizers for insufficiently correct from a point sight a condition of modern virus threats a method of valuation of quality of antiviruses.
It is interesting, that sceptically to VB concerns and successfully tested «Kaspersky’s Laboratory». «In spite of the fact that we participated in the August test and have received award VB100 of %, our relation to the given test remains invariable. We consider, that the test methodology suffers set of defects which we indicated time and again. We continue to participate in tests VB as, unfortunately, till now many customers perceive quantity of awards VB100 of % as a certain significant criterion of quality of an antivirus and even exhibit this parametre as one of conditions of tenders for choice anti-virus protection. Nevertheless, we consider possibility of an exit from tests VB in the event that the methodology of testing will not undergo changes», — the branch manager of strategic marketing «Kaspersky’s Laboratory» in region EEMEA Oleg Gudilin has declared CNews.
Michael Demidov, Cnews.ru
